Centogene N.V.
Company Snapshot
Founded: 2006
Entity Type: Public
Employees: 493
Region: Middle East
Revenue: $52.5 Millions
Revenue Year: 2023
Headquarter: Rostock, Germany
Key Geographics: North America, Europe, Middle East, Latin America, Asia-Pacific
Corporate Address: Am Strande 7 18055 Rostock Germany Tel. +49-381-80113-500 www.centogene.com
Company Overview
Centogene is a rare disease diagnostics company. It integrates multiomic technologies (phenomics, genomics, transcriptomics, epigenomics, proteomics, and metabolomics) with its proprietary Centogene Biodatabank and CentoCard-based sample logistics system to provide multidimensional analysis to guide the next generation of precision medicine. The Centogene Biodatabank is a real-world data repository for rare and neurogenerative diseases. It contains over 850,000 patient’ samples from over 120 countries, over 70% of whom are of non-European descent. CentoCard is a sample collection filter card for DNA, RNA, enzymes, and metabolic biomarker extraction.
Financial Highlights (FY 2023)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Centogene N.V. In News
Company's Business Segments
- Pharmaceutical : This segment provides a variety of products and services to its pharmaceutical partners, including target and drug screening, clinical development, market access, expansion, CENTOGENE Biodatabank Licenses, and Insight Reports.
- Diagnostics : This segment offers targeted genetic sequencing and diagnostic services to patients through its distribution partners and clients, who are typically physicians, labs, and hospitals.
Applications/End User Industries
- Pharmaceuticals
- Healthcare